The Food and Drug Administration last week authorized the emergency use of two COVID-19 molecular diagnostic tests. The tests from Inform Diagnostics Inc. and Diagnostic Solutions Laboratory LLC detect in respiratory specimens nucleic acid from SARS-CoV-2, the virus that causes COVID-19.

FDA also recently added an emergency resuscitator and a ventilator to its ventilator EAU list.

Related News Articles

Headline
The Food and Drug Administration and Centers for Disease Control and Prevention July 7 at 12 p.m. ET will host a webinar on decontaminating respirators for…
Headline
The blanket data reporting exceptions and extensions implemented in March across Medicare quality reporting and value-based payment programs for hospitals…
Headline
The House of Representatives last night passed by unanimous consent legislation (S. 4116) extending the Paycheck Protection Program loan application period…
Perspective
As James Madison wrote in the First Amendment of our Bill of Rights, we have the right to “petition the government for a redress of grievances.” We also have…
Headline
The Federal Communications Commission’s Rural Health Care Program will carry forward up to $197.98 million in unused funds from prior years to increase…
Headline
Oklahoma voters yesterday approved expanding the state’s Medicaid initiative, the first state to do so during the COVID-19 pandemic. The ballot question, which…